tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Hashimoto M et al. Feasibility of cryopreserved tracheal xenotransplants with the use of short-course immunosuppression. 2001 J. Thorac. Cardiovasc. Surg. pmid:11174729
Paller AS Use of nonsteroidal topical immunomodulators for the treatment of atopic dermatitis in the pediatric population. 2001 J. Pediatr. pmid:11174611
Hauk PJ and Leung DY Tacrolimus (FK506): new treatment approach in superantigen-associated diseases like atopic dermatitis? 2001 J. Allergy Clin. Immunol. pmid:11174211
Panhans-Gross A et al. Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506). 2001 J. Allergy Clin. Immunol. pmid:11174203
Shibazaki Y et al. Effect of the immunosuppressant drug FK506 on neonatal cerebral mitochondrial function and energy metabolism after transient intrauterine ischemia in rats. 2001 Brain Res. pmid:11172783
Manzarbeitia C et al. Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients. 2001 Liver Transpl. pmid:11172391
Bayguinov O et al. Muscarinic stimulation increases basal Ca(2+) and inhibits spontaneous Ca(2+) transients in murine colonic myocytes. 2001 Am. J. Physiol., Cell Physiol. pmid:11171588
Jørgensen PF et al. Sirolimus interferes with the innate response to bacterial products in human whole blood by attenuation of IL-10 production. 2001 Scand. J. Immunol. pmid:11169223
Boulad F et al. Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. 2000 Br. J. Haematol. pmid:11167755
Macleod MR et al. Serum withdrawal causes apoptosis in SHSY 5Y cells. 2001 Brain Res. pmid:11166724
Tanaka K et al. Immunosuppressive and non-immunosuppressive immunophilin ligands improve H(2)O(2)-induced cell damage by increasing glutathione levels in NG108-15 cells. 2001 Brain Res. pmid:11166708
Baran DA et al. Tacrolimus monotherapy in adult cardiac transplant recipients: intermediate-term results. 2001 J. Heart Lung Transplant. pmid:11166613
Wakugawa M et al. Evaluation of mite allergen-induced Th1 and Th2 cytokine secretion of peripheral blood mononuclear cells from atopic dermatitis patients: association between IL-13 and mite-specific IgE levels. 2001 J. Dermatol. Sci. pmid:11164708
Hofbauer LC et al. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. 2001 Biochem. Biophys. Res. Commun. pmid:11162519
Peeling J et al. Effect of FK-506 on inflammation and behavioral outcome following intracerebral hemorrhage in rat. 2001 Exp. Neurol. pmid:11161622
Rose N and Lever A The rapamycin sensitivity of human T-cell leukaemia virus type I-induced T-cell proliferation is mediated independently of the polypyrimidine motifs in the 5' long terminal repeat. 2001 J. Gen. Virol. pmid:11161283
Hanauer SB and Dassopoulos T Evolving treatment strategies for inflammatory bowel disease. 2001 Annu. Rev. Med. pmid:11160781
Coupes BM et al. Plasma transforming growth factor beta(1) and platelet activation: implications for studies in transplant recipients. 2001 Nephrol. Dial. Transplant. pmid:11158413
Ligtenberg G et al. Cardiovascular risk factors in renal transplant patients: cyclosporin A versus tacrolimus. 2001 J. Am. Soc. Nephrol. pmid:11158228
Prestle J et al. Overexpression of FK506-binding protein FKBP12.6 in cardiomyocytes reduces ryanodine receptor-mediated Ca(2+) leak from the sarcoplasmic reticulum and increases contractility. 2001 Circ. Res. pmid:11157671
Mathis AS and Friedman GS Coadministration of digoxin with itraconazole in renal transplant recipients. 2001 Am. J. Kidney Dis. pmid:11157404
Tolou-Ghamari Z et al. In vitro pentamer formation as a biomarker of tacrolimus-related immunosuppressive activity after liver transplantation. 2000 Clin. Chem. Lab. Med. pmid:11156362
Cather JC et al. Cyclosporine and tacrolimus in dermatology. 2001 Dermatol Clin pmid:11155577
MacDonald AS Impact of immunosuppressive therapy on hypertension. 2000 Transplantation pmid:11152235
Kainz A et al. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. 2000 Transplantation pmid:11152103
König A et al. Intravascular ultrasound for assessment of coronary allograft vasculopathy. 2000 Z Kardiol pmid:11151792
Gruber SA et al. Local drug delivery to composite tissue allografts. 2000 Microsurgery pmid:11150992
Bain JR Peripheral nerve and neuromuscular allotransplantation: current status. 2000 Microsurgery pmid:11150988
Hamar P et al. Interleukin-2-dependent mechanisms are involved in the development of glomerulosclerosis after partial renal ablation in rats. 2001 Mar-Apr Exp. Nephrol. pmid:11150862
Nagatomo I et al. Effects of MK-801, dantrolene, and FK506 on convulsive seizures and brain nitric oxide production in seizure-susceptible EL mice. 2001 Brain Res. pmid:11150489
Emre S et al. Safety and risk of using pediatric donor livers in adult liver transplantation. 2001 Liver Transpl. pmid:11150421
Remitz A et al. Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions. 2001 J. Allergy Clin. Immunol. pmid:11150013
Gondo H et al. Acquired Pelger-Huët anomaly in association with concomitant tacrolimus and fluconazole therapy following allogeneic bone marrow transplantation. 2000 Bone Marrow Transplant. pmid:11149744
Butani L and Makker SP Conversion from tacrolimus to neoral for postrenal transplant diabetes. 2000 Pediatr. Nephrol. pmid:11149106
Nghiem P "Topical immunomodulators?": introducing old friends and a new ally, tacrolimus. 2001 J. Am. Acad. Dermatol. pmid:11148486
Vallejo C et al. Resolution of cyclosporine-induced gingival hyperplasia resistant to azithromycin by switching to tacrolimus. 2001 Haematologica pmid:11146586
Drake L et al. The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. 2001 J. Am. Acad. Dermatol. pmid:11145797
Kang S et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. 2001 J. Am. Acad. Dermatol. pmid:11145796
Paller A et al. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. 2001 J. Am. Acad. Dermatol. pmid:11145795
Soter NA et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety. 2001 J. Am. Acad. Dermatol. pmid:11145794
Hanifin JM et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy. 2001 J. Am. Acad. Dermatol. pmid:11145793
Bekersky I et al. Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis. 2001 J. Am. Acad. Dermatol. pmid:11145792
Barone GW et al. The tolerability of newer immunosuppressive medications in a patient with acute intermittent porphyria. 2001 J Clin Pharmacol pmid:11144989
Haas M et al. Hypothyroidism as a cause of tacrolimus intoxication and acute renal failure: a case report. 2000 Wien. Klin. Wochenschr. pmid:11144010
Abraham KA et al. Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus. 2000 Transpl. Int. pmid:11140243
Lopau K et al. Tacrolimus in acute renal failure: does L-arginine-infusion prevent changes in renal hemodynamics? 2000 Transpl. Int. pmid:11140242
Michnick SW Chemical biology beyond binary codes. 2000 Chem. Biol. pmid:11137822
Sestak K et al. Tacrolimus-FK506 induced immunosuppression in gnotobiotic piglets. 2000 Vet. Immunol. Immunopathol. pmid:11137126
Sam WJ et al. Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients. 2000 Br J Clin Pharmacol pmid:11136292
Fischer S et al. Initial experience of combined immunosuppressive induction therapy with polyclonal antithymocyte antibody, FK 506 (tacrolimus), and prednisolone in clinical liver transplantation. 2000 Transplant. Proc. pmid:11134815
Morena M et al. Low-density lipoprotein composition and oxidation are not influenced by calcineurin inhibitors in renal transplant patients. 2000 Transplant. Proc. pmid:11134805
Tur MD et al. Apolipoprotein CIII is upregulated by anticalcineurins and rapamycin: implications in transplantation-induced dyslipidemia. 2000 Transplant. Proc. pmid:11134804
Khoury N et al. Posttransplant diabetes mellitus in kidney transplant recipients under tacrolimus immunosuppression. 2000 Transplant. Proc. pmid:11134791
Nardo B et al. Evidence of microchimerism after pretransplant blood transfusion and FK 506 in liver xenograft. 2000 Transplant. Proc. pmid:11134771
Martins L et al. Conversion to tacrolimus in case-problem kidney transplant recipients under cyclosporine-based immunosuppression. 2000 Transplant. Proc. pmid:11134735
Tanaka K et al. Immunophilin ligands prevent H2O2-induced apoptotic cell death by increasing glutathione levels in neuro 2A neuroblastoma cells. 2000 Acta Med. Okayama pmid:11132921
Morisaki T et al. A combination of cyclosporin-A (CsA) and interferon-gamma (INF-gamma) induces apoptosis in human gastric carcinoma cells. 2000 Sep- Oct Anticancer Res. pmid:11131636
Jongen VH et al. Vaginal delivery after lung transplantation. 2000 Acta Obstet Gynecol Scand pmid:11130101
Carnevale-Schianca F et al. Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease. 2000 Biol. Blood Marrow Transplant. pmid:11128811
Becker DB et al. Effects of FKBP-12 ligands following tibial nerve injury in rats. 2000 J Reconstr Microsurg pmid:11127284
Nowak JL [Adverse effects of drug interactions of cyclosporin A and tacrolimus therapy]. 2000 Pol. Merkur. Lekarski pmid:11126995
Revell MP et al. Conservation of small-airway function by tacrolimus/cyclosporine conversion in the management of bronchiolitis obliterans following lung transplantation. 2000 J. Heart Lung Transplant. pmid:11124493
Salm P et al. Evaluation of microparticle enzyme immunoassay against HPLC-mass spectrometry for the determination of whole-blood tacrolimus in heart- and lung-transplant recipients. 2000 Clin. Biochem. pmid:11124341
Arai S and Vogelsang GB Management of graft-versus-host disease. 2000 Blood Rev. pmid:11124107
England K et al. Signalling pathways regulating the dephosphorylation of Ser729 in the hydrophobic domain of protein kinase Cepsilon upon cell passage. 2001 J. Biol. Chem. pmid:11121415
Goto Y et al. Suppressive effects of cyclosporin A and FK-506 on superoxide generation in human polymorphonuclear leukocytes primed by tumor necrosis factor alpha. 2000 J. Invest. Dermatol. pmid:11121130
Frey N and Olson EN Making matters worse for a broken heart. 2000 J. Clin. Invest. pmid:11120749
Watanabe K et al. Donor bone marrow cell infusion is effective in inducing tolerance in dogs treated with fractionated lymphoid irradiation and FK506. 2000 Transplant. Proc. pmid:11120286
Ringe B et al. Replacement of corticosteroids by mycophenolate mofetil in liver graft recipients on initial tacrolimus immunosuppression. 2000 Transplant. Proc. pmid:11120285
Braun F et al. An ex vivo model to study the intestinal biotransformation of immunosuppressives. 2000 Transplant. Proc. pmid:11120282
Braun F et al. Primary tacrolimus immunosuppression in kidney recipients considered "higher immunologic risk". 2000 Transplant. Proc. pmid:11120281
Yoshida S et al. Combination therapy with FK 506 and RS61443 for rejection following allogeneic small bowel transplantation in rats. 2000 Transplant. Proc. pmid:11120262
Yamaguchi M et al. FK 506 significantly improves transferred insulin gene expression in total pancreatectomized dogs. 2000 Transplant. Proc. pmid:11120255
Jang HJ et al. Comparison of pancreas transplantation outcome between the cyclosporine and tacrolimus eras. 2000 Transplant. Proc. pmid:11120249
Imamura M et al. FK 506 inhibits severe graft-versus-host disease without mediating cytokine balance and/or cytotoxic molecules. 2000 Transplant. Proc. pmid:11120238
Tashiro H et al. Donor bone marrow perioperatively administered via portal vein induced prolongation of skin allograft survival and microchimerism in liver-transplanted rats. 2000 Transplant. Proc. pmid:11120201
Moriuchi H et al. Mechanisms of immunosuppressive effects of FK 506 in light of apoptosis of hepatocytes and infiltrating lymphocytes in rat allografted livers. 2000 Transplant. Proc. pmid:11120182
Lo CM et al. More effective immunosuppression with the use of FK506 after liver transplantation. 2000 Transplant. Proc. pmid:11120161
Oishi M et al. A case of hyperkalemic distal renal tubular acidosis secondary to tacrolimus in living donor liver transplantation. 2000 Transplant. Proc. pmid:11120143
Harihara Y et al. Correlation between graft size and necessary tacrolimus dose after living-related liver transplantation. 2000 Transplant. Proc. pmid:11120116
Koyamada N et al. Strategy for chronic rejection in recipient of living-related liver transplantation. 2000 Transplant. Proc. pmid:11120102
Sekido H et al. Successful conversion from cyclosporine to tacrolimus for immunosuppression. 2000 Transplant. Proc. pmid:11120096
Hossain MA et al. Effect of the immunosuppressants FK506 and D-allose on allogenic orthotopic liver transplantation in rats. 2000 Transplant. Proc. pmid:11120048
Fujikawa K et al. Effects of tacrolimus on rat thymic epithelial cells. 2000 Transplant. Proc. pmid:11120046
Luk JM et al. Immunosuppressive effects of Tripterygium wilfordii polysaccharide on LPS-stimulated human monocytes. 2000 Transplant. Proc. pmid:11120045
Nakao A et al. Combined effect of donor-specific bone marrow transplantation via portal vein and FK506 on small bowel transplantation in the rat. 2000 Transplant. Proc. pmid:11120044
Braun F et al. An ex vivo model to study the intestinal biotransformation of immunosuppressive drugs. 2000 Transplant. Proc. pmid:11120037
Vathsala A et al. Inhibition of apoptosis in anti-CD3-treated peripheral blood lymphocytes by immunosuppressive drugs. 2000 Transplant. Proc. pmid:11120034
Chueh SC et al. Drug fever caused by mycophenolate mofetil in a renal transplant recipient--a case report. 2000 Transplant. Proc. pmid:11120003
Shimizu T et al. Risk factors of acute tacrolimus nephrotoxicity in renal allografts. 2000 Transplant. Proc. pmid:11119998
Kim HC and Park SB Mycophenolate mofetil-induced ischemic colitis. 2000 Transplant. Proc. pmid:11119990
Shimada H et al. Existence of serum p53 antibodies in cyclosporine A-treated transplant patients: possible detection of p53 protein over-expression. 2000 Transplant. Proc. pmid:11119931
Jang HJ et al. Tacrolimus for rescue therapy in refractory renal allograft rejection. 2000 Transplant. Proc. pmid:11119925
Ichikawa Y et al. Acute rejection and the therapeutic choice of drug. 2000 Transplant. Proc. pmid:11119923
Tsang WK et al. Efficacy and safety of mycophenolate mofetil in different dosages in Asian renal allograft recipients. 2000 Transplant. Proc. pmid:11119921
Manu M et al. Impact of tacrolimus on hyperlipidemia after renal transplantation: a Japanese single center experience. 2000 Transplant. Proc. pmid:11119912
Ichikura H et al. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience. 2000 Transplant. Proc. pmid:11119911
Suzuki K et al. Effect of tacrolimus in renal transplant recipients with immunoglobulin-A nephropathy. 2000 Transplant. Proc. pmid:11119910
Toda F et al. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression. 2000 Transplant. Proc. pmid:11119909
Goto Y et al. Outcome of tacrolimus-treated renal transplantation from elderly donors. 2000 Transplant. Proc. pmid:11119908